Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

Sunny Hostin, Jedediah Bila Speak Out After Heated Vaccine Debate on ‘The View’

Newsweek reported:

Sunny Hostin and Jedediah Bila have reiterated their opposing positions on COVID-19 vaccination after their heated debate on The View.

During the remote interview, co-host Joy Behar said to Bila: “Let’s discuss the elephant in the room. You were supposed to join us in the studio weeks ago, but you couldn’t because ABC has a very strict policy that you can’t get into this building unless you’re fully vaccinated… and you made a conscious decision not to get vaccinated.”

Bila replied that she had a “medical exemption” supported by an “infectious disease specialist” and three other doctors. The former Fox News host added: “I have sky-high, multi-tiered, multi-faceted natural immunity” to the novel coronavirus. “I am not anti-vax,” Bila went on. “But what I really want is for people to make these decisions for themselves.”

After the show, Hostin shared five Instagram posts debunking Bila’s claims, with each upload starting with the words: “The following is misinformation.”

Hospitalizations Rising Among Fully Vaccinated in U.S., Fauci Says

TODAY reported:

As cases of COVID-19 rise throughout the U.S., health officials warn that an increasing number of fully vaccinated people are being hospitalized or going to the emergency room.

The concern about waning immunity against severe COVID-19 infection comes as the Food and Drug Administration is expected to authorize a Pfizer-BioNTech vaccine booster shot for all adults 18 and older.

“What we’re starting to see now is an uptick in hospitalizations among people who’ve been vaccinated but not boosted,” Dr. Anthony Fauci, the director of the National Institute for Allergy and Infectious Disease, said Tuesday in an interview.

5,300 Breakthrough COVID Cases Recorded in Massachusetts Over 1 Week

International Business Times reported:

Massachusetts health officials have recorded more than 5,300 breakthrough COVID-19 infections among its fully vaccinated residents the past week, state data shows.

Between Nov. 6 and Nov. 13, Massachusetts has recorded 5,313 new COVID-19 cases among the fully vaccinated, with at least 140 being admitted to hospitals. The state has now reported a total of 64,120 breakthrough infections and 2,080 breakthrough hospitalizations since vaccination programs began on Dec. 14, 2020.

The report did not indicate how many of the vaccinated people who were diagnosed with COVID-19 had underlying medical conditions. However, the report noted that the numbers “may be undercounted due to discrepancies” in records.

COVID Transmission in NYC Schools Remains Low This Year, City Data Suggests

New York Daily News reported:

COVID-19 spread in city schools has stayed relatively low even as students returned full-time to in-person class this year and the more infectious Delta variant surged, new city data suggests — though questions about the numbers remain.

Out of roughly 22,000 kids and staffers who were exposed to a positive COVID-19 case in school between Oct. 10 and 31, city officials identified a total of 130 who went on to get infected — an estimated “secondary attack rate” of roughly .6%, according to data from the Situation Room task force that monitors coronavirus in schools.

The Definition of ‘Fully Vaccinated’ Is Changing to Three COVID Doses

CNN reported:

You may need up to three COVID-19 vaccine doses to be considered fully vaccinated. Waning vaccine immunity and rising infections due to the Delta variant has prompted wealthy nations to reconsider the definition of “fully vaccinated” — which usually means two COVID-19 jabs.

By December 15, anyone over the age of 65 will need a third dose to revalidate their vaccination pass in France, President Emmanuel Macron announced last week. In Austria, full vaccination status expires after 9 months of the second dose, which in effect enforces booster doses.

In Israel, unless you received your second dose of the COVID-19 vaccine within the last 6 months, you now need a third dose to become eligible for a green pass, which allows entry to gyms, restaurants and other venues.

How Panic Spread in the Early Days of COVID | Opinion

Newsweek reported:

It was February 2020, and news accounts had been describing increasingly alarming information about a deadly new virus emanating from Wuhan, China. Apart from my general concern about the spread of the infection, I was confused about some of the basic numbers being aired. The overall message coming from the World Health Organization (WHO) seemed to have obvious flaws. The extremely high-risk estimates seemed very misleading.

Even worse — the reported fatality rates were based only on patients who were sick enough to seek medical care rather than on the undoubtedly much larger population of infected individuals.

I was stunned that this basic methodological flaw was being overlooked by almost everyone, while the resulting fatality rate of 3.45% was highlighted throughout the media. Every legitimate medical scientist should have called that out. Their silence was puzzling.

U.S. to Buy 10 Million Courses of Pfizer’s COVID Pill for $5.3 Billion

Reuters reported:

Pfizer Inc (PFE.N) said on Thursday it had signed a $5.29 billion deal with the U.S. government to deliver 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes to secure promising oral treatments for the disease.

The deal is roughly twice the size of the contract the U.S. government has with Merck & Co Inc (MRK.N), although the price for the Pfizer pill is lower at roughly $530 per course compared with about $700 for Merck’s.

Prophet in Purgatory

Science reported:

Peter Daszak’s life took a turn for the worse on the evening of 17 April 2020. It has yet to recover. Daszak, a conservation biologist, heads the EcoHealth Alliance, a nonprofit research group based in New York City that aims to prevent new infectious diseases from emerging.

That Friday evening, he was in the kitchen watching a White House Coronavirus Task Force press conference. A reporter asked then-President Donald Trump about supposed U.S. intelligence reports that SARS-CoV-2 came from a lab in Wuhan, China, which she claimed received $3.7 million from the U.S. National Institutes of Health (NIH).

The U.S. National Institutes of Health (NIH) had just renewed the award, which provided $3.7 million over 5 years to find and study bat coronaviruses related to SARS-CoV, which causes severe acute respiratory syndrome (SARS), the disease that nearly triggered a pandemic in 2003.

Bill Gates Says COVID Deaths Could Fall to Seasonal Flu Levels by Next Year

Entrepreneur reported:

There finally seems to be a light at the end of the pandemic’s tunnel, at least according to Microsoft founder Bill Gates.

The billionaire spoke at a conference in Singapore on Thursday, saying the number of cases and deaths from COVID-19 will be dropping “pretty dramatically.” He estimates that both rates could reach seasonal flu levels by the middle of 2022 — pending no new dangerous variants.

There were several reasons why Gates said COVID-19 cases and deaths would drop, including natural immunity and more widespread vaccine distribution. Another reason was the availability of new oral pills hitting the market.

AstraZeneca Scientist Defends Plan to Start Selling COVID Vaccine for Profit

Gizmodo reported:

A scientist who works on the AstraZeneca vaccine with Oxford University in the UK has come out to defend the decision to sell its COVID-19 vaccine at a profit, according to a new report from the Financial Times. AstraZeneca was previously unique because it sold the COVID-19 vaccine at cost, unlike most other vaccine makers like Pfizer and Moderna, which have always taken a profit.

AstraZeneca is the second-largest COVID-19 vaccine supplier in the world by volume, supplying just over 2 billion doses to date, according to the latest figures from Airfinity. Only China’s Sinovac has delivered more coronavirus vaccines, supplying the world with 2.1 billion doses. Pfizer/BioNtech has delivered 1.96 billion doses, making it third in the world.